VCIM
NXTC icon

Velan Capital Investment Management’s NextCure NXTC Stock Holding History

Velan Capital Investment Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,750
Closed -$20.7K – 56
2025
Q2 		$20.7K Buy
3,750
+1,667
+80% +$8.95K 0.02% 50
2025
Q1 		$12K Hold
2,083
– – 0.01% 46
2024
Q4 		$19.3K Buy
+2,083
New +$30.6K 0.02% 45

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CPA
Cardiff Park Advisors Carlsbad, California $1.25B AUM 24.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Velan Capital Investment Management's NXTC Position: Q3 2025 in Review

Velan Capital Investment Management sold out of NextCure (NXTC) in Q3 2025, closing a stake of 3,750 shares — an estimated $20.7K sold.

Velan Capital Investment Management first reported a position in NXTC in Q4 2024 and held it in 3 quarters. The position peaked at $20.7K in Q2 2025. 17 funds tracked by Wall St. Rank hold NXTC as of Q3 2025.

  • Velan Capital Investment Management reported no remaining NextCure position as of Q3 2025 after selling out during the quarter.
  • Velan Capital Investment Management sold 3,750 NextCure shares in Q3 2025, an estimated $20.7K.
  • Velan Capital Investment Management first reported a position in NextCure in Q4 2024 and held it in 3 quarters.
  • Velan Capital Investment Management's NextCure position peaked at $20.7K in Q2 2025.
  • 17 funds tracked by Wall St. Rank held NextCure as of Q3 2025.

Based on Velan Capital Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.